DE60032601D1 - Als antikrebsmittel verwendbare heterocyklische derivate - Google Patents
Als antikrebsmittel verwendbare heterocyklische derivateInfo
- Publication number
- DE60032601D1 DE60032601D1 DE60032601T DE60032601T DE60032601D1 DE 60032601 D1 DE60032601 D1 DE 60032601D1 DE 60032601 T DE60032601 T DE 60032601T DE 60032601 T DE60032601 T DE 60032601T DE 60032601 D1 DE60032601 D1 DE 60032601D1
- Authority
- DE
- Germany
- Prior art keywords
- anticrogen
- agents
- derivatives used
- heterocyclic derivatives
- heterocyclic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
- C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/44—Oxygen and nitrogen or sulfur and nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13493399P | 1999-05-19 | 1999-05-19 | |
US134933P | 1999-05-19 | ||
PCT/IB2000/000570 WO2000071532A1 (en) | 1999-05-19 | 2000-05-03 | Heterocyclic derivatives useful as anticancer agents |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60032601D1 true DE60032601D1 (de) | 2007-02-08 |
DE60032601T2 DE60032601T2 (de) | 2007-11-15 |
Family
ID=22465672
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60032601T Expired - Fee Related DE60032601T2 (de) | 1999-05-19 | 2000-05-03 | Als antikrebsmittel verwendbare heterocyklische derivate |
Country Status (21)
Country | Link |
---|---|
US (1) | US6380214B1 (de) |
EP (1) | EP1187826B1 (de) |
JP (2) | JP3692041B2 (de) |
AR (1) | AR029634A1 (de) |
AT (1) | ATE349440T1 (de) |
AU (1) | AU4137400A (de) |
BR (1) | BR0010746A (de) |
CA (1) | CA2374247C (de) |
CO (1) | CO5170417A1 (de) |
DE (1) | DE60032601T2 (de) |
DZ (1) | DZ3042A1 (de) |
ES (1) | ES2276681T3 (de) |
GT (1) | GT200000069A (de) |
HN (1) | HN2000000051A (de) |
MA (1) | MA26733A1 (de) |
MX (1) | MXPA01011920A (de) |
PA (1) | PA8494101A1 (de) |
PE (1) | PE20010152A1 (de) |
TN (1) | TNSN00104A1 (de) |
UY (1) | UY26143A1 (de) |
WO (1) | WO2000071532A1 (de) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8124630B2 (en) | 1999-01-13 | 2012-02-28 | Bayer Healthcare Llc | ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
EP2298311B1 (de) | 1999-01-13 | 2012-05-09 | Bayer HealthCare LLC | Omega-carboxyarylsubstituierte-Diphenyl-Harnstoffe als p38-Kinasehemmer |
WO2001057034A1 (en) | 2000-02-07 | 2001-08-09 | Bristol-Myers Squibb Co. | 3-aminopyrazole inhibitors of cyclin dependent kinases |
GB0003154D0 (en) | 2000-02-12 | 2000-04-05 | Astrazeneca Uk Ltd | Novel compounds |
US7105682B2 (en) | 2001-01-12 | 2006-09-12 | Amgen Inc. | Substituted amine derivatives and methods of use |
US7102009B2 (en) | 2001-01-12 | 2006-09-05 | Amgen Inc. | Substituted amine derivatives and methods of use |
US8329924B2 (en) * | 2001-06-11 | 2012-12-11 | Vertex Pharmaceuticals (Canada) Incorporated | Compounds and methods for the treatment or prevention of Flavivirus infections |
PL208713B1 (pl) * | 2001-06-11 | 2011-05-31 | Virochem Pharma Inc | Związek stanowiący pochodną tiofenu, kompozycja farmaceutyczna zawierająca taki związek i jego zastosowanie |
SE0102617D0 (sv) * | 2001-07-25 | 2001-07-25 | Astrazeneca Ab | Novel compounds |
SE0102616D0 (sv) * | 2001-07-25 | 2001-07-25 | Astrazeneca Ab | Novel compounds |
US6924276B2 (en) | 2001-09-10 | 2005-08-02 | Warner-Lambert Company | Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors |
MXPA04007832A (es) | 2002-02-11 | 2005-09-08 | Bayer Pharmaceuticals Corp | Aril-ureas con actividad inhibitoria de angiogenesis. |
US20030216396A1 (en) | 2002-02-11 | 2003-11-20 | Bayer Corporation | Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitors |
US6989451B2 (en) * | 2002-06-04 | 2006-01-24 | Valeant Research & Development | Heterocyclic compounds and uses thereof |
AU2003232551A1 (en) * | 2002-06-13 | 2003-12-31 | Qlt Inc. | Methods of using isothiazole derivatives to treat cancer or inflammation |
AU2003248896B2 (en) * | 2002-07-09 | 2010-04-22 | Fasgen, Llc | Methods of treating microbial infections in humans and animals |
SG169236A1 (en) * | 2002-07-09 | 2011-03-30 | Fasgen Inc | Novel compunds, pharmaceutical compositions containing same, and methods of use for same |
AU2003281664A1 (en) * | 2002-07-25 | 2004-02-16 | Pfizer Products Inc. | Isothiazole derivatives useful as anticancer agents |
US7626031B2 (en) * | 2002-11-15 | 2009-12-01 | Symphony Evolution, Inc. | Substituted 3-(diarylmethylene)indolin-2-ones and methods of their use |
PT1569929E (pt) | 2002-12-10 | 2010-06-18 | Virochem Pharma Inc | Compostos e métodos para o tratamento ou prevenção de infecções por flavivírus |
SE0300091D0 (sv) * | 2003-01-15 | 2003-01-15 | Astrazeneca Ab | Novel compounds |
SE0300092D0 (sv) * | 2003-01-15 | 2003-01-15 | Astrazeneca Ab | Novel compounds |
WO2004078723A1 (ja) * | 2003-03-07 | 2004-09-16 | Santen Pharmaceutical Co. Ltd. | 4-ピリジルアルキルチオ基を置換基として有する新規化合物 |
CA2526617C (en) | 2003-05-20 | 2015-04-28 | Bayer Pharmaceuticals Corporation | Diaryl ureas with kinase inhibiting activity |
UA84156C2 (ru) | 2003-07-23 | 2008-09-25 | Байер Фармасьютикалс Корпорейшн | Фторозамещённая омега-карбоксиарилдифенилмочевина для лечения и профилактики болезней и состояний |
JP4626353B2 (ja) * | 2004-02-17 | 2011-02-09 | 参天製薬株式会社 | 置換又は無置換アミノ基を導入した4−ピリジルアルキルチオ基を有する新規環式化合物 |
PL1717229T3 (pl) * | 2004-02-17 | 2011-11-30 | Santen Pharmaceutical Co Ltd | Nowy cykliczny związek mający grupę 4-pirydyloalkilotiolową z wprowadzoną do niej (nie)podstawioną grupą aminową |
ES2368153T3 (es) * | 2004-02-17 | 2011-11-14 | Santen Pharmaceutical Co., Ltd. | Nuevo compuesto cíclico que presenta un grupo 4-piridilalquiltio que presenta amino (no) sustituido introducido en el mismo. |
AU2005223483B2 (en) | 2004-03-18 | 2009-04-23 | Zoetis Llc | N-(1-arylpyrazol-4l)sulfonamides and their use as parasiticides |
EP1751139B1 (de) | 2004-04-30 | 2011-07-27 | Bayer HealthCare LLC | Substituierte pyrazolyl-harnstoff-derivate zur behandlung von krebs |
BRPI0514667A (pt) * | 2004-08-26 | 2008-06-17 | Pfizer Prod Inc | processos para a preparação de derivados de isotiazol |
JP4585978B2 (ja) * | 2005-03-03 | 2010-11-24 | 参天製薬株式会社 | キノリルアルキルチオ基を有する新規環式化合物 |
EA016071B1 (ru) * | 2005-05-13 | 2012-01-30 | Вирокем Фарма Инк. | Соединения и способы лечения или предотвращения флавивирусных инфекций |
US7932390B2 (en) | 2006-06-29 | 2011-04-26 | Hoffman-La Roche Inc. | Substituted thieno[3,2-C]pyridine carboxylic acid derivatives |
RS52874B (en) | 2006-11-15 | 2013-12-31 | Vertex Pharmaceuticals Incorporated | THYOPHEN ANALYSIS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS |
EP2116530B1 (de) * | 2007-02-26 | 2012-11-14 | Santen Pharmaceutical Co., Ltd | Neuartige pyrrolderivate mit einer ureidgruppe und einer aminocarbonylgruppe als substituenten |
WO2008153042A1 (ja) * | 2007-06-11 | 2008-12-18 | Kyowa Hakko Kirin Co., Ltd. | 抗腫瘍剤 |
MX2010001636A (es) | 2007-08-14 | 2010-03-15 | Hoffmann La Roche | Derivados de pirazolo[3,4-d]-pirimidina como agentes antiproliferativos. |
JP2012531433A (ja) * | 2009-06-25 | 2012-12-10 | メドリューション リミテッド | キナーゼ阻害剤としての置換複素環式化合物とその用法 |
CN104302640A (zh) | 2012-03-16 | 2015-01-21 | 埃克希金医药品有限公司 | 3,5-二氨基吡唑激酶抑制剂 |
NZ631142A (en) | 2013-09-18 | 2016-03-31 | Axikin Pharmaceuticals Inc | Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors |
MY191736A (en) | 2014-12-23 | 2022-07-13 | Axikin Pharmaceuticals Inc | 3,5-diaminopyrazole kinase inhibitors |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1950990A1 (de) * | 1968-10-17 | 1970-05-14 | Ciba Geigy | Verfahren zur Herstellung von neuen triazacyclischen Verbindungen |
GB1355513A (en) * | 1971-04-07 | 1974-06-05 | May & Baker Ltd | Isothiazole derivatives |
DE2408234A1 (de) * | 1974-02-21 | 1975-09-04 | Celamerck Gmbh & Co Kg | Isothiazolylharnstoffe |
US4057416A (en) * | 1976-06-18 | 1977-11-08 | Fmc Corporation | 3-Alkylthio-, 3-alkylsulfinyl-, and 3-alkylsulfonylisothiazole derivatives as herbicides |
US4075001A (en) * | 1976-06-18 | 1978-02-21 | Fmc Corporation | 3-Aminoisothiazole derivatives as herbicides |
US4059433A (en) * | 1976-06-18 | 1977-11-22 | Fmc Corporation | 3-Alkoxyisothiazole derivatives as herbicides |
DE3529247A1 (de) * | 1985-05-17 | 1986-11-20 | Bayer Ag, 5090 Leverkusen | Verwendung von thienylharnstoffen und -isoharnstoffen als leistungsfoerdernde mittel bei tieren, neue thienylharnstoffe und -isoharnstoffe und ihre herstellung |
DE3540377A1 (de) * | 1985-11-14 | 1987-05-21 | Bayer Ag | Thienooxazinone, verfahren zu ihrer herstellung und ihre verwendung als leistungsfoerderer |
DE3541631A1 (de) * | 1985-11-26 | 1987-05-27 | Bayer Ag | Selektiv-fungizide verwendung von thienylharnstoff-derivaten |
US4859699A (en) * | 1987-07-20 | 1989-08-22 | Sandoz Ltd. | Substituted N-benzoyl-N'-thienylureas |
US6177401B1 (en) | 1992-11-13 | 2001-01-23 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften | Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis |
DE4328425A1 (de) * | 1993-08-24 | 1995-03-02 | Basf Ag | Acylamino-substituierte Isoxazol- bzw. Isothiazolderivate, Verfahren zu deren Herstellung und ihre Verwendung |
TW276256B (de) * | 1993-08-26 | 1996-05-21 | Takeda Pharm Industry Co Ltd | |
ATE262902T1 (de) * | 1994-11-10 | 2004-04-15 | Millennium Pharm Inc | Verwendung von pyrazole verbindungen zur behandlung von glomerulonephritis, krebs, atherosklerose oder restenose |
US5792767A (en) * | 1995-01-27 | 1998-08-11 | Abbott Laboratories | Bicyclic substituted hexahydrobenz e! isoindole alpha-1 adrenergic antagonists |
US5773459A (en) * | 1995-06-07 | 1998-06-30 | Sugen, Inc. | Urea- and thiourea-type compounds |
AU7585598A (en) * | 1997-05-23 | 1998-12-11 | Bayer Corporation | Raf kinase inhibitors |
US6037340A (en) * | 1997-05-28 | 2000-03-14 | Cadus Pharmaceutical Corporation | Synthesis and use of thiophene- and pyrrole-based heteroaromatic compounds |
UA60365C2 (uk) * | 1998-06-04 | 2003-10-15 | Пфайзер Продактс Інк. | Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця |
-
2000
- 2000-04-12 HN HN2000000051A patent/HN2000000051A/es unknown
- 2000-04-17 CO CO00028307A patent/CO5170417A1/es not_active Application Discontinuation
- 2000-04-17 US US09/549,893 patent/US6380214B1/en not_active Expired - Fee Related
- 2000-04-18 PA PA20008494101A patent/PA8494101A1/es unknown
- 2000-05-03 MX MXPA01011920A patent/MXPA01011920A/es active IP Right Grant
- 2000-05-03 DE DE60032601T patent/DE60032601T2/de not_active Expired - Fee Related
- 2000-05-03 JP JP2000619789A patent/JP3692041B2/ja not_active Expired - Lifetime
- 2000-05-03 CA CA002374247A patent/CA2374247C/en not_active Expired - Fee Related
- 2000-05-03 AU AU41374/00A patent/AU4137400A/en not_active Abandoned
- 2000-05-03 BR BR0010746-8A patent/BR0010746A/pt not_active Application Discontinuation
- 2000-05-03 WO PCT/IB2000/000570 patent/WO2000071532A1/en active IP Right Grant
- 2000-05-03 AT AT00920969T patent/ATE349440T1/de not_active IP Right Cessation
- 2000-05-03 EP EP00920969A patent/EP1187826B1/de not_active Expired - Lifetime
- 2000-05-03 ES ES00920969T patent/ES2276681T3/es not_active Expired - Lifetime
- 2000-05-15 UY UY26143A patent/UY26143A1/es not_active Application Discontinuation
- 2000-05-16 PE PE2000000458A patent/PE20010152A1/es not_active Application Discontinuation
- 2000-05-17 MA MA25977A patent/MA26733A1/fr unknown
- 2000-05-17 TN TNTNSN00104A patent/TNSN00104A1/fr unknown
- 2000-05-17 DZ DZ000085A patent/DZ3042A1/xx active
- 2000-05-17 GT GT200000069A patent/GT200000069A/es unknown
- 2000-05-17 AR ARP000102369A patent/AR029634A1/es not_active Application Discontinuation
-
2004
- 2004-07-20 JP JP2004211640A patent/JP2005008641A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
PA8494101A1 (es) | 2003-09-05 |
JP3692041B2 (ja) | 2005-09-07 |
CO5170417A1 (es) | 2002-06-27 |
CA2374247A1 (en) | 2000-11-30 |
MXPA01011920A (es) | 2002-05-06 |
HN2000000051A (es) | 2001-02-02 |
EP1187826A1 (de) | 2002-03-20 |
CA2374247C (en) | 2008-01-22 |
GT200000069A (es) | 2001-11-08 |
TNSN00104A1 (fr) | 2005-11-10 |
BR0010746A (pt) | 2002-02-13 |
DZ3042A1 (fr) | 2004-03-27 |
MA26733A1 (fr) | 2004-12-20 |
AU4137400A (en) | 2000-12-12 |
PE20010152A1 (es) | 2001-02-08 |
UY26143A1 (es) | 2000-12-29 |
ATE349440T1 (de) | 2007-01-15 |
JP2003500401A (ja) | 2003-01-07 |
WO2000071532A1 (en) | 2000-11-30 |
EP1187826B1 (de) | 2006-12-27 |
US6380214B1 (en) | 2002-04-30 |
ES2276681T3 (es) | 2007-07-01 |
DE60032601T2 (de) | 2007-11-15 |
AR029634A1 (es) | 2003-07-10 |
JP2005008641A (ja) | 2005-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60032601D1 (de) | Als antikrebsmittel verwendbare heterocyklische derivate | |
DE60020812D1 (de) | Heteroaryl-substituierte chinolin-2-on derivate verwendbar als antikrebsmittel | |
DE69920009D1 (de) | Isothiazole derivate verwendbar als antikrebsmittel | |
CY2016002I2 (el) | Ν-υποκατεστημενο καρβαμουλοξυαλκυλιο - παραγωγα αζολιου | |
DE69930518D1 (de) | Als antikrebsmittel verwendbare alkinyl-substituierte chinolin-2-on-derivate | |
ATE261933T1 (de) | Admantan derivate | |
ATE359275T1 (de) | Substituierte bizyclische derivate verwendbar als antitumor mittel | |
DE60010448D1 (de) | Amid-derivate | |
ATE330954T1 (de) | Quinazolin-derivate als vegf-hemmer | |
NO20022095D0 (no) | Heterocyklisk substituerte pyrazoloner | |
DE60019577D1 (de) | 4, 5, 6, 7-tetrahydroindazolderivate als antitumormittel | |
ATE263748T1 (de) | Admantan-derivate | |
ATE293104T1 (de) | Thiazolylamid-derivate | |
DE60013127D1 (de) | 5-phenyl-pyrimidine derivate | |
ATE338021T1 (de) | Substituierte 2-dialkylaminoalkylbiphenyl- derivate | |
ATE257148T1 (de) | Propargyletherderivate | |
ATE254621T1 (de) | Thienoisoxazolyl- und thienylpyrazolyl-phenoxy substituierte propyl derivate als d4 antagonisten | |
ATE245640T1 (de) | Heterocyclische benzolsulfonamidderivate als bradykinin antagonisten | |
ATE374747T1 (de) | Monofluoralkylderivate | |
ATE273272T1 (de) | Mevinolinderivate | |
DE60025918D1 (de) | 4-phenyl-pyrimidine derivate | |
ATE293592T1 (de) | Resorcinderivate | |
ATE254598T1 (de) | 4-hydroxybiphenylhydrazid-derivate | |
DE60003072D1 (de) | Thiazolidindion-derivate als antidiabetika | |
DE50115858D1 (de) | Heterocyclische aminoalkylpyridinderivate als psychopharmaka |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8328 | Change in the person/name/address of the agent |
Representative=s name: DERZEIT KEIN VERTRETER BESTELLT |
|
8339 | Ceased/non-payment of the annual fee |